p53 as a target for anti-cancer drug development
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference126 articles.
1. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis;Bartkova;Nature,2005
2. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions;Gorgoulis;Nature,2005
3. The IARC TP53 database: new online mutation analysis and recommendations to users;Olivier;Hum Mutat,2002
4. TP53 and mutations in human cancer;Szymanska;Acta Biochim Pol,2003
5. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations;Cho;Science,1994
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Trehalose and its Diverse Biological Potential;Current Protein & Peptide Science;2023-07
2. Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach;Molecules;2023-03-27
3. Multifaceted functions of RPS27a: An unconventional ribosomal protein;Journal of Cellular Physiology;2022-12-29
4. Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview;Genes and Environment;2021-04-21
5. Synthesis of Copolymers Polyethyleneimine‐ co ‐Polyphenylalanine as Gene and Drug Codelivery Carrier;Macromolecular Bioscience;2021-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3